Atıf Formatları
Lentiviral micro-dystrophin gene treatment into late-stage mdx mice for Duchene Muscular Dystrophy disease.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. A. Eren Et Al. , "Lentiviral micro-dystrophin gene treatment into late-stage mdx mice for Duchene Muscular Dystrophy disease.," Current gene therapy , 2023

Eren, S. A. Et Al. 2023. Lentiviral micro-dystrophin gene treatment into late-stage mdx mice for Duchene Muscular Dystrophy disease.. Current gene therapy .

Eren, S. A., Tastan, C., Karadeniz, K. B., Turan, R. D., Cakirsoy, D., Kancagi, D. D., ... Yilmaz, S. U.(2023). Lentiviral micro-dystrophin gene treatment into late-stage mdx mice for Duchene Muscular Dystrophy disease.. Current gene therapy .

Eren, Selen Et Al. "Lentiviral micro-dystrophin gene treatment into late-stage mdx mice for Duchene Muscular Dystrophy disease.," Current gene therapy , 2023

Eren, Selen A. Et Al. "Lentiviral micro-dystrophin gene treatment into late-stage mdx mice for Duchene Muscular Dystrophy disease.." Current gene therapy , 2023

Eren, S. A. Et Al. (2023) . "Lentiviral micro-dystrophin gene treatment into late-stage mdx mice for Duchene Muscular Dystrophy disease.." Current gene therapy .

@article{article, author={Selen Abanuz Eren Et Al. }, title={Lentiviral micro-dystrophin gene treatment into late-stage mdx mice for Duchene Muscular Dystrophy disease.}, journal={Current gene therapy}, year=2023}